Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 point » _ point (Expand Search)
-
13301
Behavior effects after LABP acute exposure.
Published 2022“…Asterisks indicate statistical differences between groups (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). n = 24/group a-20 min; 28/group b-20 min; 28/group c-25 min; 50/group d-60 min.…”
-
13302
-
13303
-
13304
-
13305
Impaired bone formation in <i>Col1a1-Krm2</i> transgenic mice.
Published 2013“…<p>(A) Toluidine blue staining of non-decalcified vertebral body sections from 6 weeks old female wildtype and <i>Col1a1-Krm2</i> transgenic littermates revealing that the normal appearance of cuboidal osteoblasts (arrows) covering trabecular bone surfaces is only observed in wildtype controls (scale bars, 50 µm). …”
-
13306
Barbie audit data.
Published 2025“…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
-
13307
The FEET system of barbie categorisation.
Published 2025“…</p><p>Main outcome measures</p><p>Over time there was a decreased prevalence in equinus foot posture from 100% in the first time period to 40% in the last. …”
-
13308
S1 Graphical abstract -
Published 2025“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
-
13309
The top 10 hub targets.
Published 2025“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
-
13310
Original images for blots and gels requirements.
Published 2025“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
-
13311
The top 10 active ingredients.
Published 2025“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
-
13312
-
13313
The flow chart.
Published 2025“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
-
13314
The active ingredients in RB-HMM.
Published 2025“…<div><p>A number of studies demonstrate the therapeutic effectiveness of <i>Radix Bupleuri</i> (RB) and <i>Hedysarum Multijugum Maxim</i> (HMM) in treating liver fibrosis, but the exact molecular mechanisms remain unclear. …”
-
13315
Physiologic values.
Published 2023“…The serum syndecan-1 concentration, a glycocalyx component, in the 4% hydrogen group (5.7 ± 4.4 pg/mL) was lower than in the control (19.5 ± 6.6 pg/mL) and 2% hydrogen (19.8 ± 5.0 pg/mL) groups (<i>P</i> < 0.001 for each), but it was not significantly different from the sham group (6.2 ± 4.0 pg/mL, <i>P</i> = 0.999). …”
-
13316
-
13317
-
13318
-
13319
Cox analysis.
Published 2025“…</p><p>Conclusions</p><p>Factors associated with survival were arterial hypertension and iROX < 3.85 with a mortality hazard of 1.5 times, age older than 60 years, and respiratory effort scale at admission WOB ≥ 4 points with more than twice the mortality hazard. …”
-
13320
Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial
Published 2013“…The follow-up ended in January 2010, and lasted for 7.7–106.4 months with a median of 47.6 months. TTR was significantly longer in the <sup>125</sup>I group (mean of 60.0 months vs. 36.7 months in the control). …”